AIML Innovations Appoints Jared Adelstein to Board of Directors
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has announced the appointment of Jared Adelstein to its Board of Directors, effective immediately. This strategic addition aims to strengthen the company's governance and accelerate commercialization efforts in the AI-powered healthcare space.
Adelstein brings strategic, financial, and operational expertise in guiding high-growth companies through important development stages. The appointment aligns with AIML's mission to deliver innovative AI solutions in healthcare and enhance its leadership team during a period of strategic growth.
AIML operates through its subsidiaries Quantum Sciences , NeuralCloud Solutions Inc, AI Rx Inc., and maintains strategic partnerships with Health Gauge Inc. (95.2% owned by AIML). The company focuses on AI and machine learning applications in digital health and wellbeing solutions.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) ha annunciato la nomina di Jared Adelstein nel proprio Consiglio di Amministrazione, con effetto immediato. Questa aggiunta strategica mira a rafforzare la governance dell'azienda e a accelerare gli sforzi di commercializzazione nel settore sanitario potenziato dall'intelligenza artificiale.
Adelstein apporta competenze strategiche, finanziarie e operative nella guida di aziende ad alta crescita attraverso fasi di sviluppo cruciali. La nomina è in linea con la missione di AIML di offrire soluzioni AI innovative in ambito sanitario e di potenziare il team di leadership durante un periodo di crescita strategica.
AIML opera tramite le sue controllate Quantum Sciences, NeuralCloud Solutions Inc, AI Rx Inc., e mantiene partnership strategiche con Health Gauge Inc. (di cui detiene il 95,2%). L'azienda si concentra su applicazioni di intelligenza artificiale e machine learning per soluzioni digitali dedicate alla salute e al benessere.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) ha anunciado el nombramiento de Jared Adelstein en su Junta Directiva, con efecto inmediato. Esta incorporación estratégica tiene como objetivo fortalecer la gobernanza de la empresa y acelerar los esfuerzos de comercialización en el ámbito de la salud impulsada por inteligencia artificial.
Adelstein aporta experiencia estratégica, financiera y operativa en la dirección de empresas de alto crecimiento durante etapas clave de desarrollo. El nombramiento está alineado con la misión de AIML de ofrecer soluciones innovadoras de IA en salud y reforzar su equipo directivo en un período de crecimiento estratégico.
AIML opera a través de sus subsidiarias Quantum Sciences, NeuralCloud Solutions Inc, AI Rx Inc., y mantiene alianzas estratégicas con Health Gauge Inc. (de la cual posee el 95,2%). La compañía se enfoca en aplicaciones de inteligencia artificial y aprendizaje automático para soluciones digitales de salud y bienestar.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)는 즉시 발효되는 Jared Adelstein의 이사회 임명을 발표했습니다. 이 전략적 인사는 회사의 거버넌스를 강화하고 AI 기반 헬스케어 분야에서 상용화 노력을 가속화하는 것을 목표로 합니다.
Adelstein은 고성장 기업들을 중요한 개발 단계에서 이끌어온 전략적, 재무적, 운영적 전문성을 제공합니다. 이번 임명은 혁신적인 AI 헬스케어 솔루션 제공과 전략적 성장기 동안 리더십 팀 강화를 목표로 하는 AIML의 사명과 일치합니다.
AIML은 자회사 Quantum Sciences, NeuralCloud Solutions Inc, AI Rx Inc를 통해 운영되며, Health Gauge Inc.(AIML이 95.2% 소유)와 전략적 파트너십을 유지하고 있습니다. 회사는 디지털 건강 및 웰빙 솔루션에서 AI와 머신러닝 응용에 집중하고 있습니다.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) a annoncé la nomination de Jared Adelstein à son conseil d'administration, avec effet immédiat. Cette addition stratégique vise à renforcer la gouvernance de l'entreprise et à accélérer les efforts de commercialisation dans le domaine des soins de santé propulsés par l'IA.
Adelstein apporte une expertise stratégique, financière et opérationnelle pour accompagner les entreprises à forte croissance lors de phases de développement cruciales. Cette nomination s'inscrit dans la mission d'AIML de fournir des solutions innovantes en IA pour la santé et de renforcer son équipe dirigeante en période de croissance stratégique.
AIML opère à travers ses filiales Quantum Sciences, NeuralCloud Solutions Inc, AI Rx Inc., et maintient des partenariats stratégiques avec Health Gauge Inc. (dont AIML détient 95,2 %). L'entreprise se concentre sur les applications d'intelligence artificielle et d'apprentissage automatique dans les solutions numériques de santé et de bien-être.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) hat die sofortige Ernennung von Jared Adelstein in den Vorstand bekanntgegeben. Diese strategische Ergänzung soll die Unternehmensführung stärken und die Kommerzialisierungsbemühungen im Bereich der KI-gestützten Gesundheitsversorgung beschleunigen.
Adelstein bringt strategische, finanzielle und operative Expertise mit, um wachstumsstarke Unternehmen durch wichtige Entwicklungsphasen zu führen. Die Ernennung steht im Einklang mit AIMLs Mission, innovative KI-Lösungen im Gesundheitswesen bereitzustellen und das Führungsteam in einer Phase strategischen Wachstums zu verstärken.
AIML operiert über seine Tochtergesellschaften Quantum Sciences, NeuralCloud Solutions Inc., AI Rx Inc. und unterhält strategische Partnerschaften mit Health Gauge Inc. (zu 95,2 % im Besitz von AIML). Das Unternehmen konzentriert sich auf KI- und Machine-Learning-Anwendungen im Bereich digitale Gesundheits- und Wohlfühllösungen.
- Strategic appointment strengthens board expertise in high-growth company development
- 95.2% ownership stake in Health Gauge Inc. demonstrates strong market position
- Multi-exchange listing provides broader investor access and liquidity
- None.
Strategic Addition to the Board Strengthens Governance and Accelerates Commercialization Efforts
VANCOUVER, BC / ACCESS Newswire / April 22, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce the appointment of Jared Adelstein to its Board of Directors ("Board"), effective immediately. This appointment is part of AIML's broader effort to strengthen its leadership team as the Company enters an exciting phase of strategic growth and commercialization in the artificial intelligence ("AI")-powered healthcare space.
Jared brings strategic, financial and operational expertise, with experience in guiding high-growth companies through pivotal stages of development. His appointment aligns with AIML's commitment to enhancing governance and strategic leadership as the Company moves forward with its mission to deliver innovative AI solutions in healthcare.
Paul Duffy, CEO of AIML, stated: "We are delighted to welcome Jared to our Board. His strategic insight and proven experience will be invaluable as we continue to scale AIML and leverage our unique AI-driven healthcare technologies."
Commenting on his appointment, Jared said: "I'm excited to join the Board at such a pivotal time in the Company's evolution. With a clear strategic direction and a world-class leadership team in place, I look forward to supporting AIML as it advances its vision through this important growth period."
AIML remains steadfast in its mission to deliver breakthrough solutions at the intersection of AI and human health. Jared's addition to AIML's Board helps bolster our leadership team and marks another meaningful step forward in realizing that vision.
For more information about AIML:
For detailed information please see AIML's website or the Company's filed documents at www.sedarplus.ca.
Contact:
Blake Fallis
(778) 405-0882
info@aiml-innovations.com
About AI/ML Innovations Inc. https://aiml-innovations.com/
AIML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence: (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through its wholly owned subsidiaries, Quantum Sciences Ltd. and NeuralCloud Solutions Inc, AI Rx Inc., strategic partnerships with Health Gauge Inc. (
On behalf of the Board of Directors:
Paul Duffy, Chairman
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements - Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.
SOURCE: AI/ML Innovations, Inc.
View the original press release on ACCESS Newswire
FAQ
What is the significance of Jared Adelstein joining AIML's Board of Directors?
What are AIML's (AIMLF) main business segments and subsidiaries?
How does AIMLF stock trade internationally?
What is AIML's strategic focus in the healthcare sector?
